Evaluation of the Impact of the Cancer Therapy Everolimus on the Central Nervous System in Mice

• Martine Dubois,

  Affiliations Inserm U982, Laboratory of Neuronal and Neuroendocrine Communication and Differentiation (DC2N), Astrocyte and Vascular Niche, University of Rouen, Mont-Saint-Aignan, France, PRES Normandie Université, Institute of Research and Biomedical Innovation (IRIB), University of Rouen, Mont-Saint-Aignan, France, North-West Cancéropole (CNO), Lille, France

  ⨯
• Vadim Le Joncour,

  Affiliations Inserm U982, Laboratory of Neuronal and Neuroendocrine Communication and Differentiation (DC2N), Astrocyte and Vascular Niche, University of Rouen, Mont-Saint-Aignan, France, PRES Normandie Université, Institute of Research and Biomedical Innovation (IRIB), University of Rouen, Mont-Saint-Aignan, France

  ⨯
• Marie-Christine Tonon,

  Affiliations Inserm U982, Laboratory of Neuronal and Neuroendocrine Communication and Differentiation (DC2N), Astrocyte and Vascular Niche, University of Rouen, Mont-Saint-Aignan, France, PRES Normandie Université, Institute of Research and Biomedical Innovation (IRIB), University of Rouen, Mont-Saint-Aignan, France

  ⨯
• Youssef Anouar,

  Affiliations Inserm U982, Laboratory of Neuronal and Neuroendocrine Communication and Differentiation (DC2N), Astrocyte and Vascular Niche, University of Rouen, Mont-Saint-Aignan, France, PRES Normandie Université, Institute of Research and Biomedical Innovation (IRIB), University of Rouen, Mont-Saint-Aignan, France

  ⨯
• François Proust,

  Affiliations Inserm U982, Laboratory of Neuronal and Neuroendocrine Communication and Differentiation (DC2N), Astrocyte and Vascular Niche, University of Rouen, Mont-Saint-Aignan, France, PRES Normandie Université, Institute of Research and Biomedical Innovation (IRIB), University of Rouen, Mont-Saint-Aignan, France

  ⨯
• Fabrice Morin,

  Affiliations Inserm U982, Laboratory of Neuronal and Neuroendocrine Communication and Differentiation (DC2N), Astrocyte and Vascular Niche, University of Rouen, Mont-Saint-Aignan, France, PRES Normandie Université, Institute of Research and Biomedical Innovation (IRIB), University of Rouen, Mont-Saint-Aignan, France

  ⨯
• Pierrick Gandolfo,

  Affiliations Inserm U982, Laboratory of Neuronal and Neuroendocrine Communication and Differentiation (DC2N), Astrocyte and Vascular Niche, University of Rouen, Mont-Saint-Aignan, France, PRES Normandie Université, Institute of Research and Biomedical Innovation (IRIB), University of Rouen, Mont-Saint-Aignan, France, North-West Cancéropole (CNO), Lille, France

  ⨯
• Florence Joly,

  Affiliations North-West Cancéropole (CNO), Lille, France, EA4700, Laboratory of Psychology and Neurosciences of Cognition and Affectivity (PSY-NCA), University of Rouen, Mont-Saint-Aignan, France, Centre François Baclesse, Caen, France, Centre Hospitalo-Universitaire, Caen, France

  ⨯
• Pascal Hilber,

  Affiliations North-West Cancéropole (CNO), Lille, France, EA4700, Laboratory of Psychology and Neurosciences of Cognition and Affectivity (PSY-NCA), University of Rouen, Mont-Saint-Aignan, France

  ⨯
• Hélène Castel

  * E-mail: helene.castel@univ-rouen.fr

  Affiliations Inserm U982, Laboratory of Neuronal and Neuroendocrine Communication and Differentiation (DC2N), Astrocyte and Vascular Niche, University of Rouen, Mont-Saint-Aignan, France, PRES Normandie Université, Institute of Research and Biomedical Innovation (IRIB), University of Rouen, Mont-Saint-Aignan, France, North-West Cancéropole (CNO), Lille, France

  ⨯